Merck (MRK) stock gains as BMO Capital Markets upgrades the company to Outperform citing strong portfolio moves before ...

BMO Capital analyst Keith Bachman raised the firm’s price target on Accenture (ACN) to $300 from $270 and keeps a Market ...

On December 16, BMO Capital raised its price target on Amazon.com, Inc. (NASDAQ:AMZN) to $304 from $300 and kept an ...

Gold prices could extend their rally into early 2026, with spot levels potentially moving sharply higher, according to BMO Capital’s latest metals outlook.

Fintel reports that on December 18, 2025, BMO Capital maintained coverage of Progressive (NYSE:PGR) with a Market Perform ...

LyondellBasell Industries ( LYB) on Monday was downgraded to Underperform from a previous investment rating of Market Perform ...

Sales trends showed modest improvement in November, but excess inventory and growing dealer fatigue continue to pressure the ...

While acknowledging that Keytruda’s loss of exclusivity in 2028 represents the largest patent cliff in biopharma, BMO said it ...

After a series of unfortunate regulatory rejections and manufacturing issues surfaced, Regeneron’s shares dipped to $483 this ...

Guggenheim Securities announced that Simeon Siegel, formerly at BMO Capital Markets, has joined the firm’s Equity Research Department as a senior managing director and consumer equity research analyst ...

On December 3, BMO Capital’s Evan Seigerman increased the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $372 from $335 ...

BMO Capital Markets, the investment banking arm of the Bank of Montreal, has acquired the Chicago-based broker-dealer Griffin, Kubik, Stephens & Thompson Inc., further expanding into the U.S. public ...